AAAAAA
Results: 51-75/85
Authors:
SCHAEFER HG
TOUBLANC N
WEIMANN HJ
Citation: Hg. Schaefer et al., THE PHARMACOKINETICS OF MOXONIDINE, Reviews in contemporary pharmacotherapy, 9(7), 1998, pp. 481-490
Authors:
SIDES GD
LESCHINGER MI
WALENTA R
MCNAY JL
Citation: Gd. Sides et al., THE TOLERABILITY AND ADVERSE EVENT PROFILE OF MOXONIDINE, Reviews in contemporary pharmacotherapy, 9(7), 1998, pp. 491-499
Authors:
GUNZLER WA
Citation: Wa. Gunzler, SARUPLASE - BACKGROUND AND BIOCHEMISTRY, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 355-362
Authors:
COHEN AF
KOSTER RW
Citation: Af. Cohen et Rw. Koster, THE CLINICAL PHARMACOKINETICS OF SARUPLASE, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 363-370
Authors:
SPIECKER M
DARIUS H
MEYER J
Citation: M. Spiecker et al., ANGIOGRAPHIC STUDIES OF SARUPLASE IN THE TREATMENT OF MYOCARDIAL-INFARCTION, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 371-377
Authors:
BAR FW
SPANJERS MHA
HOPKINS G
Citation: Fw. Bar et al., BOLUS ADMINISTRATION OF THROMBOLYTIC THERAPY, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 379-384
Authors:
VERMEER F
Citation: F. Vermeer, THE ADVERSE EVENT AND TOLERABILITY PROFILE OF SARUPLASE, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 385-393
Authors:
TEBBE U
HOPKINS G
Citation: U. Tebbe et G. Hopkins, MORTALITY-RATES WITH SARUPLASE, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 395-401
Authors:
MICHELS HR
Citation: Hr. Michels, THE IMPORTANCE OF SARUPLASE IN THE CONTEXT OF OTHER THROMBOLYTIC MEDICATIONS, Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 403-409
Authors:
HORST WD
PRESKORN SH
Citation: Wd. Horst et Sh. Preskorn, THE PHARMACOLOGY AND MODE OF ACTION OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 293-302
Authors:
BURNETT FE
DINAN TG
Citation: Fe. Burnett et Tg. Dinan, THE CLINICAL EFFICACY OF VENLAFAXINE IN THE TREATMENT OF DEPRESSION, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 303-320
Authors:
NUTT D
JOHNSON FN
Citation: D. Nutt et Fn. Johnson, POTENTIAL APPLICATIONS OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 321-331
Authors:
SINCLAIR J
BIRTWISTLE J
BALDWIN D
Citation: J. Sinclair et al., THE TOLERABILITY OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 333-344
Authors:
ISKEDJIAN M
EINARSON TR
FASSOS FF
Citation: M. Iskedjian et al., PHARMACOECONOMIC ASPECTS OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 345-353
Authors:
WALKERBONE K
ARDEN N
COOPER C
Citation: K. Walkerbone et al., EPIDEMIOLOGIC ASPECTS OF OSTEOPOROSIS, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 225-231
Authors:
EBETINO FH
FRANCIS MD
ROGERS MJ
RUSSELL RGG
Citation: Fh. Ebetino et al., MECHANISMS OF ACTION OF ETIDRONATE AND OTHER BISPHOSPHONATES, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 233-243
Authors:
FOGELMAN I
BLAKE G
Citation: I. Fogelman et G. Blake, EARLY POSTMENOPAUSAL BONE LOSS AND INTERMITTENT CYCLICAL ETIDRONATE THERAPY, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 245-254
Authors:
MILLER PD
Citation: Pd. Miller, EFFICACY AND SAFETY OF CYCLICAL ETIDRONATE THERAPY IN THE LONG-TERM TREATMENT OF OSTEOPOROSIS, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 255-260
Authors:
FRANCIS RM
Citation: Rm. Francis, CYCLICAL ETIDRONATE IN THE MANAGEMENT OF OSTEOPOROSIS IN MEN, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 261-266
Authors:
ADACHI JD
Citation: Jd. Adachi, CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION AND TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 267-275
Authors:
VANSTAA TP
Citation: Tp. Vanstaa, POSTMARKETING EXPERIENCE WITH INTERMITTENT CYCLICAL ETIDRONATE THERAPY, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 277-286
Authors:
REID DM
TORGERSON DJ
Citation: Dm. Reid et Dj. Torgerson, PHARMACOECONOMIC ASPECTS OF INTERMITTENT CYCLICAL ETIDRONATE THERAPY IN THE TREATMENT OF POSTMENOPAUSAL AND CORTICOSTEROID-INDUCED OSTEOPOROSIS, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 287-292
Authors:
COLEMAN RE
Citation: Re. Coleman, PAMIDRONATE DISODIUM IN THE TREATMENT AND MANAGEMENT OF HYPERCALCEMIA, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 147-164
Authors:
CHAKRAVARTY K
CRISP A
Citation: K. Chakravarty et A. Crisp, PAMIDRONATE DISODIUM IN PAGETS-DISEASE OF BONE, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 165-181
Authors:
IDDON J
BUNDRED N
HOWELL T
Citation: J. Iddon et al., PAMIDRONATE DISODIUM IN THE TREATMENT OF OSTEOLYTIC LESIONS AND BONE PAIN IN PATIENTS WITH BONE METASTASES ASSOCIATED WITH BREAST-CANCER, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 183-193